{"id":"W2063432158","doi":"10.1007/s10637-011-9719-0","title":"SWOG 0514: a phase II study of sorafenib in patients with unresectable or metastatic gallbladder carcinoma and cholangiocarcinoma","year":2011,"lang":"en","type":"article","venue":"Investigational New Drugs","topic":"Cholangiocarcinoma and Gallbladder Cancer Studies","field":"Medicine","cited_by":167,"is_retracted":false,"has_abstract":false,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"National Cancer Institute","keywords":"Sorafenib; Medicine; Internal medicine; Gallbladder; Gastroenterology; Oncology; Carcinoma; Hepatocellular carcinoma; Stage (stratigraphy); Chemotherapy; Gallbladder cancer","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003343249,0.001806035,0.003213156,0.0006994082,0.0005668968,0.00106494,0.0009434691,0.0009602834,0.003085611],"category_scores_gemma":[0.001555958,0.0009009663,0.002567558,0.0008004168,0.001278347,0.001462613,0.0006103276,0.00284073,0.0005935458],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00116014,"about_ca_system_score_gemma":0.003063823,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001915357,"about_ca_topic_score_gemma":0.006044092,"domain_scores_codex":[0.9991012,0.000579303,0.00005122026,0.00008212253,0.00005227923,0.0001338971],"domain_scores_gemma":[0.9989128,0.0002218646,0.000189667,0.00009387192,0.00007645165,0.0005053153],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.8113683,0.0409826,0.03477513,0.00165122,0.00606119,0.0002763639,0.0004179105,0.002223189,0.0144802,0.0003614047,0.004466065,0.08293644],"study_design_scores_gemma":[0.6564785,0.2995722,0.03440046,0.00004934148,0.002219566,0.0003278341,0.0002015131,0.000924896,0.001944466,0.00016647,0.00365684,0.00005791236],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9949981,0.002284264,0.0002065649,0.0003763201,0.0001059709,0.0007266558,0.000595706,0.00003590621,0.0006704669],"genre_scores_gemma":[0.9885698,0.003253387,0.001399285,0.0007985196,0.000207794,0.001524666,0.002545807,0.00003114834,0.001669595],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.003343249,"threshold_uncertainty_score":0.017681,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.04928934074195547,"score_gpt":0.2755956105989698,"score_spread":0.2263062698570143,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}